As Omicron surge, officials alert that caution and COVID protocol is the ‘only’ option, Health News, ET HealthWorld

New Delhi: In view of the rapid rise witnessed in COVID cases detected in the country, the same preventive strategy following all restrictive measures should be put in place by the state governments that can only help in preventing the spread of all COVID variants, top Union Health Ministry officials, informed Thursday.

“The government is following the test, track, treat and vaccinate strategy whilst preparing the overall health infrastructure to tackle any possible surge in COVID cases,” said Dr VK Paul, Health Official, Niti Aayog.

Lav Agarwal, Joint Secretary, Union Health Ministry highlighted that the COVID numbers are surging across the nation with the average daily cases for the past one week rising to 8,009. The active cases now stand at 82,402 with Kerala ( 25.66%) and Maharashtra (21.33%) contributing the maximum number of active cases.

Speaking about the surge in cases witnessed in the country, Dr VK Paul, Health Official, Niti Aayog said, “There is an uptick in the number of COVID cases as can be seen by the number of cases recorded in the last 24 hours. Delhi, Maharashtra or Mumbai in particular, Punjab, Haryana, Jharkhand, Chhattisgarh among many states are showing a rise in cases and an

View More As Omicron surge, officials alert that caution and COVID protocol is the ‘only’ option, Health News, ET HealthWorld

Russian drug Avifavir shows effectiveness in slowing COVID progression, Health News, ET HealthWorld

New Delhi: Following the results obtained from clinical trials, ChemRar Group announced that the Russian version of globally recognised drug Favipiravir, Avifavir, is highly effective against various variants of COVID including Delta and Omicron. It affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp) via three complementary mechanisms, resulting in complete blockade of the viral infection.

The group had introduced Avifavir in the market back in June 2020 with the help of Russian Direct Investment Fund (RDIF), becoming the first pharmaceutical group to release a direct antiviral for COVID-19 treatment. The product’s efficacy was confirmed with a full-scale clinical trial in Russia involving 460 COVID patients. The antiviral drug is currently being supplied to more than 15 countries around the world as part of the COVID treatment.

A meta-analysis of 23 COVID-19 treatment studies for favipiravir demonstrated a 47 percent improvement when Favipiravir is used in early treatment of coronavirus. The clinical trials of Avifavir have demonstrated the presence of anti-COVID properties, such as alleviating symptoms and cutting the duration of the disease by half compared to the standard therapy.

The clinical trials conducted for the medicinal drug Avifavir also proved that the virus is incapable of

View More Russian drug Avifavir shows effectiveness in slowing COVID progression, Health News, ET HealthWorld

India may face intense but short outbreak as Omicron spreads, Health News, ET HealthWorld

India may see a spurt in Covid-19 growth rate within days and head into an intense but short-lived virus wave as the highly-infectious omicron variant moves through the crowded nation of almost 1.4 billion.

“It is likely that India will see a period of explosive growth in daily cases and that the intense growth phase will be relatively short,” Paul Kattuman, professor at the Judge Business School at the University of Cambridge which has developed a Covid-19 India tracker, wrote in an email.

“New infections will begin to rise in a few days, possibly within this week,” he said, adding that it was hard to predict how high the daily cases could go.

Kattuman and his team of researchers, developers of the India Covid tracker, are seeing a sharp rise in infection rates across India.

The tracker spotlighted six states as a “significant concern” in a December 24 note, with adjusted growth rate of new cases exceeding 5%. This had expanded to 11 Indian states by December 26, according to the tracker, which corrects for “day of the week effects” and other variations.

India, which has confirmed 34.8 million infections and 480,290 deaths so far, is already gearing up to

View More India may face intense but short outbreak as Omicron spreads, Health News, ET HealthWorld